Publikationsdatenbank

Die Publikationsdatenbank enthält alle Artikel von HZI-Mitarbeitenden (ehemals Gesellschaft für Biotechnologische Forschung (GBF)) seit 2000.

Cornberg,M., Lok,A.S., Terrault,N.A., Zoulim,F. (2020)
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
J.Hepatol. 72 (3)
Maasoumy,B., Geretti,A.M., Frontzek,A., Austin,H., Aretzweiler,G., Garcia-Álvarez,M., Leuchter,S., Simon,C.O., Marins,E.G., Canchola,J.A., Cornberg,M., ... , Delgado,R., Wedemeyer,H. (2020)
HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination
Hepatol.Commun. 4 (7)
Yang,D., Dai,Z., Yang,T., Balakrishnan,A., Yuan,Q., Vondran,F.W.R., Manns,M.P., Ott,M., ... , Cantz,T., Sharma,A.D. (2020)
MicroRNA-125b-5p Regulates Hepatocyte Proliferation During the Termination Phase of Liver Regeneration
Hepatol.Commun. 4 (12)
Sara,A.A., Um-E-Farwa,, Saeed,A., Kalesse,M. (2021)
Recent Applications of the Diels-Alder Reaction in the Synthesis of Natural Products (2017-2020)
Synthesis
Maharachchikumbura,S.S.N., Chen,Y., Ariyawansa,H.A., Hyde,K.D., Haelewaters,D., Perera,R.H., Samarakoon,M.C., Wanasinghe,D.N., Bustamante,D.E., Liu,J.K., Lawrence,D.P., ... , Cheewangkoon,R., Stadler,M. (2021)
Integrative approaches for species delimitation in Ascomycota
Fungal Diversity
Schütte,K., Schulz,C., Vilchez-Vargas,R., Vasapolli,R., Palm,F., Simon,B., Schomburg,D., Lux,A., Geffers,R., Pieper,D.H., ... , Link,A., Malfertheiner,P. (2021)
Impact of healthy aging on active bacterial assemblages throughout the gastrointestinal tract
Gut Microbes 13 (1)
Friedrich,C., Taggenbrock,R.L.R.E., Doucet-Ladeveze,R., Golda,G., Moenius,R., Arampatzi,P., Kragten,N.A.M., Kreymborg,K., Gomez de Agüero,M., Kastenmüller,W., Saliba,A.E., Grün,D., ... , van Gisbergen,K.P.J.M., Gasteiger,G. (2021)
Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues
Nat.Immunol.
Crous,P.W., Lombard,L., Sandoval-Denis,M., Seifert,K.A., Schroers,H.J., Chaverri,P., Gene,J., Guarro,J., Hirooka,Y., Bensch,K., Kema,G.H.J., Lamprecht,S.C., Cai,L., Rossman,A.Y., Stadler,M., Summerbell,R.C., Taylor,J.W., Ploch,S., Visagie,C.M., Yilmaz,N., Frisvad,J.C., Abdel-Azeem,A.M., Abdollahzadeh,J., Abdolrasouli,A., Akulov,A., Alberts,J.F., Araujo,J.P.M., Ariyawansa,H.A., Bakhshi,M., Bendiksby,M., Ben Hadj Amor,A., Bezerra,J.D.P., Boekhout,T., Camara,M.P.S., Carbia,M., Cardinali,G., Castaneda-Ruiz,R.F., Celis,A., Chaturvedi,V., Collemare,J., Croll,D., Damm,U., Decock,C.A., de Vries,R.P., Ezekiel,C.N., Fan,X.L., Fernandez,N.B., Gaya,E., Gonzalez,C.D., Gramaje,D., Groenewald,J.Z., Grube,M., Guevara-Suarez,M., Gupta,V.K., Guarnaccia,V., Haddaji,A., Hagen,F., Haelewaters,D., Hansen,K., Hashimoto,A., Hernandez-Restrepo,M., Houbraken,J., Hubka,V., Hyde,K.D., Iturriaga,T., Jeewon,R., Johnston,P.R., Jurjevic,Z, Karalti,I., Korsten,L., Kuramae,E.E., Kusan,I., Labuda,R., Lawrence,D.P., Lee,H.B., Lechat,C., Li,H.Y., Litovka,Y.A., Maharachchikumbura,S.S.N., Marin-Felix,Y., Matio Kemkuignou,B., Matocec,N., McTaggart,A.R., Mlcoch,P., Mugnai,L., Nakashima,C., Nilsson,R.H., Noumeur,S.R., Pavlov,I.N., Peralta,M.P., Phillips,A.J.L., Pitt,J.I., Polizzi,G., Quaedvlieg,W., Rajeshkumar,K.C., Restrepo,S., Rhaiem,A., Robert,J., Robert,V., Rodrigues,A.M., Salgado-Salazar,C., Samson,R.A., Santos,A.C.S., Shivas,R.G., Souza-Motta,C.M., Sun,G.Y., Swart,W.J., Szoke,S., Tan,Y.P., Taylor,J.E., Taylor,P.W.J., Tiago,P.V., Vaczy,K.Z., van de Wiele,N., van der Merwe,N.A., Verkley,G.J.M., Vieira,W.A.S., Vizzini,A., Weir,B.S., Wijayawardene,N.N., Xia,J.W., Yanez-Morales,M.J., Yurkov,A., Zamora,J.C., Zare,R., ... , Zhang,C.L., Thines,M. (2021)
Fusarium: more than a node or a foot-shaped basal cell
Stud.Mycol. 98 (April 2021)
Kuhnert,E., Navarro-Munoz,J.C., Becker,K., Stadler,M., Collemare,J., Cox,R.J. (2021)
Secondary metabolite biosynthetic diversity in the fungal family Hypoxylaceae and Xylaria hypoxylon
Stud.Mycol. 99 (June 2021)
Kazmaier,U., Junk,L. (2021)
Recent developments on the synthesis and bioactivity of ilamycins/rufomycins and cyclomarins, marine cyclopeptides that demonstrate anti-malaria and anti-tuberculosis activity
Mar.Drugs 19 (8)